NOSU
NOTICE OF SUIT
05/26/2026
Back to search
Official data from USPTO
EURO PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
05/27/2026
Classification
Registered
Trademark type
Combined
Nice classes
3, 5
Filing date
12/27/2001
Registration date
12/30/2003
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/22/2021
Last transaction
05/27/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/10/2003
First use in commerce
04/10/2003
Drawing code
5
Owner type
03
Owner location
GREEN BAY, WI, US
Examiner
GOODSAID, IRA
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
EUROPHARMA, INC.
LEMEROND, TERRENCE J.
Representatives
L. S. VanLandingham III
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
cosmetics and non-medicated skin care preparationsskin lotionsskin emollientsskin gelsskin moisturizersskin toners and skin conditioners
Class 5
dietaryherbalmineral and nutritional supplements; pharmaceuticals for the treatment of coughsbronchial congestionacneheadachescold and flu symptomsdrowsinessfatigueallergy and asthma symptomssleeplessnesspremenstrual and menstrual problemsminor anxietynervous tensionstressweight losssneezingupset stomachnauseaflakinessirritation or itchiness of the skinburningirritations and pain of the eyes and nasal passages
Publications
History of USPTO decisions and trademark events.
39 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/01/2023
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
11/01/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/01/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/01/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
05/08/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/30/2022
TMBN
TTAB RELEASE CASE TO TRADEMARKS
02/22/2021
CANT
CANCELLATION TERMINATED NO. 999999
02/22/2021
CAND
CANCELLATION DENIED NO. 999999
02/22/2021
PETC
CANCELLATION INSTITUTED NO. 999999
07/09/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/08/2016
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/10/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/10/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/10/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/10/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
03/26/2013
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
12/31/2009
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/31/2009
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/31/2009
E15R
TEAS SECTION 15 RECEIVED
12/21/2009
ES8R
TEAS SECTION 8 RECEIVED
12/21/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
12/30/2003
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/04/2003
DOCK
ASSIGNED TO EXAMINER
11/04/2003
CFIT
CASE FILE IN TICRS
11/03/2003
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/22/2003
IUAF
USE AMENDMENT FILED
09/23/2003
PAPER RECEIVED
09/23/2003
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/25/2003
PUBO
PUBLISHED FOR OPPOSITION
12/31/2002
NPUB
NOTICE OF PUBLICATION
12/11/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/25/2002
CNEA
EXAMINERS AMENDMENT MAILED
10/23/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2002
PAPER RECEIVED
09/20/2002
DOCK
ASSIGNED TO EXAMINER
09/11/2002
CNRT
NON-FINAL ACTION MAILED
03/21/2002
DOCK
ASSIGNED TO EXAMINER
03/13/2002
Continuous trademark protection
Get notified about every new filing that threatens EURO PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.